2 mg semaglutide to tirzepatide (MOUNJARO®/ZEPBOUND) vs (OZEMPIC®/WEGOVY®) for Weight Loss Treatment – Medical Weight Loss Training Tirzepatide 10 and 15 mg

Examination of the relationship between obesity and suicidal ideation

Seek urgent medical advice if you experience: Severe or persistent gastrointestinal symptoms: Whilst mild nausea is common with Wegovy, severe or persistent vomiting, severe abdominal pain (especially if radiating to the back), or signs of dehydration require immediate assessment, as these may indicate pancreatitis or other serious complications

And also very, very happy to be here

By providing access to licensed healthcare providers through our telehealth platform, we ensure that every participant has a personalized plan tailored to their specific health needs

Complete a telehealth visit

Do non-GLP weight-loss drugs still have a role